Pilot evaluation of the clinical use of transcutaneous aortovelography has been undertaken and suggests that this technique will be useful in the assessment of left ventricular function in the acutely ill patient. Changes in waveform as a result of therapy or alteration in clinical condition can frequently be noted by critical visual assessment. Increasing clinical experence suggests that quantification will permit interpretation of less obvious changes in the recorded waveform. Transcutaneous aortovelography has the simplicity, speed, and safety afforded by a non-invasive technique.
The treatment of a critically ill patient necessitates ultrasonic beam with blood flow in the transverse the use of various measurements to serve as guide arch of the aorta. The controls which are conlines in patient management. These measurements stantly used during recording-recorder on/off, should be reliable, easily obtainable, reproducible, display intensity, and an event marker-are on a and preferably non-invasive.
small, hand-held, remote control box so that one In the management of these patients a com-person can conveniently operate the instrument promise has frequently to be reached between (Fig. 1) . obtaining objective indices and initiating therapy A reproducible recording could be obtained in based on clinical assessment. Rapid deterioration in approximately 90 per cent of patients. Difficulties the patient's condition may necessitate 'blind' arose in patients with pulmonary emphysema and therapy which, if inappropriate, may lead to further in those who were restless or could not lie flat. deterioration.
There is a need for a rapid, reliable technique for the repeated measurement of left ventricular 1i output, so that changes in output can be observed.
Transcutaneous aortovelography may meet this requirement. This preliminary report describes the use of this technique in an Intensive Therapy Unit. The instrumentation and basic principles of the technique have been described in the preceding paper (Sequeira et al., 1976) .
Method
The method is described in the preceding paper (Sequeira et al., 1976) . Clinical experience has FIG. 1 Hand-held remote control box used in conshown that the transducer usually has to point junction with non-invasive haemotachograph (see downwards and to the left in order to align the Fig. 1 of Sequeira et al., 1976) by their low Doppler shifts and diastolic timing. expressed i cm/s. Fig. 3 shows how these calculaChanges in the volume flow entering the de-tions are made. When respiratory variations are scending aorta can be calculated from changes in present, the record is analysed over a number of maximum aortic velocities on the assumptions that respiratory cycles. So far, these calculations have the cross-sectional area of the vessel, its velocity been made in a few patients only.
profile, and the proportion of blood supplying the head, upper limbs, and coronary arteries (all of Subjects studied which is lost to measurement) remains constant Over a period of 4 months recordings were obtained between observations. Initially we found that visual from 68 subjects, 21 of whom were healthy volunassessment of the record gave useful sequential teers. A total of 47 patients were studied (Table) . (Fig. 7) . The mean 0 2 'Shock' an amylobarbitone overdose. Fig. 11 shows the Serial recordings were obtained in shocked patients various observations made. At the time of admisfrom the time of admission to the Intensive Therapy sion, the central venous pressure was high, the Unit; additional records were made when a drug or pulse rate was 150/min, and the blood pressure unmanoeuvre was expected to affect the haemody-recordable. The mean aortic blood velocity was low. namic status of the patient. Whenever possible These findings were consistent with the diagnosis of appearances were interpreted in the light of changes 'shock' secondary to a fall in cardiac output, prein pulse rate, blood pressure, central venous sumably a result of the myocardial suppressant pressure, urine output, and skin-core temperature effect of amylobarbitone. In view of these changes differences.
an isoprenaline infusion was started. This was followed by a fall in the central venous pressure, a Hypovolaemic shock rising blood pressure, a steady increase in urine
Recordings from patients admitted in hypo-output, and a dramatic increase in the mean aortic Volaemic shock consistently showed a low peak and blood velocity. It was possible to regulate the dosage mean velocity, short ejection time, and small area. of isoprenaline infused in order to maintain an Fig. 8 shows the sequential changes in transcu-improved but submaximal mean velocity and a taneous aortovelograph recordings from a patient pulse rate of 110/min or less. admitted with shock and treated by fluid replacement. Fig. 9 shows the various observations made during the treatment of shock. The systolic blood Conclusion pressure was unrecordable on admission and the mean velocity recorded by transcutaneous aorto-Our limited experience suggests that sequential velography was extremely low. Fluid therapy transcutaneous aortovelograph recordings in con-(combination of purified protein fraction and junction with other clinical indices may be of value crystalloids) was begun on the basis of these in the management of hypovolaemic shock and findings and of evidence of fluid loss over the response to fluid therapy, and as an indicator of the previous week. A central venous pressure line was effect of a drug on the cardiovascular system. not established until an hour later, but the measured They may also prove to be of particular value in the central venous pressure was then less than zero assessment of the therapeutic effect of inotropic (mid-thorax reference level) after intravenous in-agents and agents producing peripheral vasodilatafusion 800 ml in one hour. With increasing volumes tion, so that a titrated dose can then be administered of fluid infused, there was a steady increase in mean intravenously. aortic velocity, central venous pressure, and blood Transcutaneous aortovelography has the adpressure; the skin-core temperature difference de-vantage over many other techniques for assessment creased as peripheral perfusion improved. Records of cardiovascular function being non-invasive. from patients with myocardial failure showed a Recordings can be obtained from approximately 90 similar appearance to those from patients in hypo-per cent of critically ill patients and sequential volaemic shock, but these patients usually had a observations made with little patient discomfort. raised central venous pressure and did not show A pilot evaluation suggests that this technique improvement after a fluid challenge. On the other provides useful information on cardiovascular hand, mean aortic velocity rapidly increased with a status, and that serial records can give a guide to fluid challenge in hypovolaemic patients and this progress and response to therapy. Simple quantitawas associated with a simultaneous increase in tive analysis of the tracings is likely to increase central venous pressure. their value.
Septic shock In this condition, transcutaneous aortovelograph appearances are variable. Interpretation of these Reference records will require detailed measurements and Sequeira, R. F., Light, L. H., Cross, G., and Raftery, E. B. correlation with other cardiovascular indices in (1976) . Transcutaneous aortovelography-a quantitative order to determine whether the technique will evaluation. British Heart Journal, 37, prove of value in the management of this condition.
Drug overdose and drug response
Requests for reprints to Dr. Gillian C. Hanson, Fig. 10 shows sequential transcutaneous aortovelo-Whipps Cross Hospital, Leytonstone, London Ell graph recordings taken from a patient admitted with 1NR.
